BMEA insider filings
Biomea Fusion, Inc. — 47 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-06-12. Screen BMEA transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for BMEA between 2026-07-10 and 2026-10-08. The table below lists the most recent filings on record.
Recent insider filings — Biomea Fusion, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-12 | 4 | Averill Julianne — Director | Grant/award (A): 173,711 (derivative) @ $0 | EDGAR |
| 2026-06-12 | 4 | Ray Sumita — Director | Grant/award (A): 196,299 (derivative) @ $0 | EDGAR |
| 2026-06-12 | 4 | Faust Elizabeth — Director | Grant/award (A): 196,299 (derivative) @ $0 | EDGAR |
| 2026-06-12 | 4 | AGUIAR ERIC — Director | Grant/award (A): 196,299 (derivative) @ $0 | EDGAR |
| 2026-04-03 | 4 | Hitchcock Michael J.M. — Interim CEO, Director | Grant/award (A): 667,477 (derivative) @ $0 | EDGAR |
| 2026-04-03 | 4 | Erdtmann Rainer M — See Remarks, Director | Grant/award (A): 452,512 (derivative) @ $0 | EDGAR |
| 2025-12-15 | 4 | Erdtmann Rainer M — See Remarks, Director | Purchase (P): 30,000 @ $1.43 | EDGAR |
| 2025-12-04 | 4 | Hitchcock Michael J.M. — Interim CEO, Director | Purchase (P): 100,000 @ $0.99 | EDGAR |
| 2025-12-02 | 4 | Erdtmann Rainer M — See Remarks, Director | Purchase (P): 40,000 @ $1.10 · Purchase (P): 10,000 @ $1.05 | EDGAR |
| 2025-08-13 | 4 | Hitchcock Michael J.M. — Interim CEO, Director | Grant/award (A): 916,434 (derivative) @ $0 | EDGAR |
| 2025-08-13 | 4 | Erdtmann Rainer M — See Remarks, Director | Gift (G): 40,000 @ $0 · Gift (G): 10,000 @ $0 · Gift (G): 10,000 @ $0 · Gift (G): 10,000 @ $0 · Gift (G): 10,000 @ $0 · Gift (G): 10,000 @ $0 · +2 more | EDGAR |
| 2025-08-01 | 4 | Chen Bihua Cormorant Global Healthcare Master Fund, LP Cormorant Private Healthcare Fund III LP Cormorant Asset Management, LP | Holdings only — no transactions reported | EDGAR |
| 2025-07-24 | 4 | Averill Julianne — Director | Grant/award (A): 241,177 (derivative) @ $0 | EDGAR |
| 2025-06-13 | 4 | Chen Bihua — Director, 10% owner Cormorant Global Healthcare Master Fund, LP — 10% owner Cormorant Private Healthcare Fund III LP — 10% owner Cormorant Asset Management, LP — 10% owner | Grant/award (A): 91,970 (derivative) @ $0 | EDGAR |
| 2025-06-13 | 4 | Ray Sumita — Director | Grant/award (A): 91,970 (derivative) @ $0 | EDGAR |
| 2025-06-13 | 4 | Faust Elizabeth — Director | Grant/award (A): 91,970 (derivative) @ $0 | EDGAR |
| 2025-06-13 | 4 | AGUIAR ERIC — Director | Grant/award (A): 91,970 (derivative) @ $0 | EDGAR |
| 2025-03-28 | 4 | Hitchcock Michael J.M. — Interim CEO, Director | Grant/award (A): 350,000 (derivative) @ $0 | EDGAR |
| 2024-12-02 | 4 | Valle Franco — Chief Financial Officer | Grant/award (A): 495 @ $6.15 | EDGAR |
| 2024-10-01 | 4 | Hitchcock Michael J.M. — Director | Purchase (P): 10,000 @ $10.06 | EDGAR |
| 2024-06-13 | 4 | Hitchcock Michael J.M. — Director | Grant/award (A): 51,025 (derivative) @ $0 | EDGAR |
| 2024-06-13 | 4 | Chen Bihua — Director, 10% owner Cormorant Global Healthcare Master Fund, LP — 10% owner Cormorant Private Healthcare Fund III LP — 10% owner Cormorant Asset Management, LP — 10% owner | Grant/award (A): 51,025 (derivative) @ $0 | EDGAR |
| 2024-06-13 | 4 | Ray Sumita — Director | Grant/award (A): 51,025 (derivative) @ $0 | EDGAR |
| 2024-06-13 | 4 | Faust Elizabeth — Director | Grant/award (A): 51,025 (derivative) @ $0 | EDGAR |
| 2024-06-13 | 4 | AGUIAR ERIC — Director | Grant/award (A): 51,025 (derivative) @ $0 | EDGAR |
| 2024-06-12 | 4 | Frias Juan Pablo — Chief Medical Officer | Grant/award (A): 349 @ $8.94 | EDGAR |
| 2024-06-12 | 4 | Valle Franco — Chief Financial Officer | Grant/award (A): 4,448 @ $3.78 · Purchase (P): 12,509 @ $4.43 | EDGAR |
| 2024-01-18 | 4 | Butler Thomas Andrew — Chief Executive Officer, Director, 10% owner | Grant/award (A): 407,502 (derivative) @ $0 | EDGAR |
| 2024-01-18 | 4 | Frias Juan Pablo — Chief Medical Officer | Grant/award (A): 111,090 (derivative) @ $0 | EDGAR |
| 2024-01-18 | 4 | Valle Franco — Chief Financial Officer | Grant/award (A): 145,245 (derivative) @ $0 | EDGAR |
| 2024-01-18 | 4 | Erdtmann Rainer M — President and COO, Director | Grant/award (A): 135,700 (derivative) @ $0 | EDGAR |
| 2024-01-03 | 4 | Erdtmann Rainer M — President and COO, Director | Gift (G): 3,000 @ $0 · Gift (G): 3,000 @ $0 · Gift (G): 3,000 @ $0 · Gift (G): 3,000 @ $0 · Gift (G): 3,000 @ $0 · Gift (G): 3,000 @ $0 · +1 more | EDGAR |
| 2023-12-01 | 4 | Valle Franco — Chief Financial Officer | Grant/award (A): 1,345 @ $3.78 | EDGAR |
| 2023-09-01 | 4 | Frias Juan Pablo — Chief Medical Officer | Grant/award (A): 300,000 (derivative) @ $0 | EDGAR |
| 2023-06-16 | 4 | Hitchcock Michael J.M. — Director | Grant/award (A): 6,989 (derivative) @ $0 | EDGAR |
| 2023-06-16 | 4 | Chen Bihua — Director, 10% owner Cormorant Global Healthcare Master Fund, LP — 10% owner Cormorant Private Healthcare Fund III LP — 10% owner Cormorant Asset Management, LP — 10% owner | Grant/award (A): 6,989 (derivative) @ $0 | EDGAR |
| 2023-06-16 | 4 | Ray Sumita — Director | Grant/award (A): 6,989 (derivative) @ $0 | EDGAR |
| 2023-06-16 | 4 | Faust Elizabeth — Director | Grant/award (A): 6,989 (derivative) @ $0 | EDGAR |
| 2023-06-16 | 4 | AGUIAR ERIC — Director | Grant/award (A): 6,989 (derivative) @ $0 | EDGAR |
| 2023-06-02 | 4 | A2A Pharmaceuticals, Inc. — 10% owner | Sale (S): 75,000 @ $33.81 · Sale (S): 50,000 @ $34.56 | EDGAR |
| 2023-06-02 | 4 | Valle Franco — Chief Financial Officer | Grant/award (A): 4,273 @ $3.78 | EDGAR |
| 2023-05-17 | 4 | A2A Pharmaceuticals, Inc. — 10% owner | Sale (S): 25,000 @ $33.84 | EDGAR |
| 2023-05-10 | 4 | A2A Pharmaceuticals, Inc. — 10% owner | Sale (S): 100,000 @ $33.99 · Sale (S): 150,000 @ $34.50 | EDGAR |
| 2023-04-26 | 4 | A2A Pharmaceuticals, Inc. — 10% owner | Sale (S): 200,000 @ $29.12 | EDGAR |
| 2023-04-06 | 4 | A2A Pharmaceuticals, Inc. — 10% owner | Sale (S): 200,000 @ $31.25 | EDGAR |
| 2023-04-06 | 4/A | A2A Pharmaceuticals, Inc. — 10% owner | Sale (S): 200,000 @ $31.25 | EDGAR |
| 2023-04-03 | 4 | Chen Bihua — Director, 10% owner Cormorant Global Healthcare Master Fund, LP — 10% owner Cormorant Private Healthcare Fund III LP — 10% owner Cormorant Asset Management, LP — 10% owner | Purchase (P): 400,000 @ $30 | EDGAR |
Recent 8-K events — Biomea Fusion, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-09-22 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-08-05 | 8-K | 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-11 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-05-11 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-28 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-24 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-25 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-14 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-04 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-10-07 | 8-K | 1.01 — Entry into a Material Definitive Agreement 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=BMEA returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →